Skip to search formSkip to main contentSkip to account menu

polyestradiol phosphate

Known as: polyestradiol phosphate [Chemical/Ingredient], Estradiol Phosphate Polymer, Estra-1,3,5(10)-triene-3,17 diol (17-beta)-, polymer with phosporic acid 
A synthetic long-acting polymer derivative of the female sex hormone estradiol. As the primary, most potent estrogen hormone produced by the ovaries… 
National Institutes of Health

Related topics

Related topics

19 relations
CYP1A2 protein, humanCYP3A7 protein, humanDrug AllergyHot flushes

Broader (3)

EstradiolEstrogenspolyestradiol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer
The purpose of this study was to investigate the prognostic value of different forms of the urokinase receptor, uPAR, in serum… 
Highly Cited
2001
Highly Cited
2001
Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
Highly Cited
2000
Highly Cited
2000
Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group…
1997
1997
Possible bone‐preserving capacity of high‐dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma
Treatment of prostatic disease with GnRH agonists or by orchidectomy affects bone mass negatively. Estrogen treatment has… 
Highly Cited
1996
Highly Cited
1996
Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
When given orally, estrogens, as well as androgens, lower serum lipoprotein (a)[Lp(a)]levels. To determine whether these effects… 
1995
1995
Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden…
Highly Cited
1994
Highly Cited
1994
Circadian changes of serum prolactin levels and tuberoinfundibular dopaminergic neuron activities in ovariectomized rats treated with or without estrogen: the role of the suprachiasmatic nuclei.
Variations of serum prolactin (PRL) levels and activities of tuberoinfundibular dopaminergic (TIDA) neurons during the afternoon… 
Highly Cited
1985
Highly Cited
1985
Central nervous system regions involved in the estrogen-induced afternoon prolactin surge. I. Lesion studies.
Central nervous system regions were examined in long term ovariectomized rats to determine if they are involved in the estrogen… 
Highly Cited
1975
Highly Cited
1975
Treatment of prostatic carcinoma with various types of estrogen derivatives.
1971
1971
Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol.
  • G. Jönsson
  • Scandinavian Journal of Urology and Nephrology
  • 1971
  • Corpus ID: 194635
One-hundred-and-twenty-six patients with prostatic carcinoma were treated with polyestradiolphosphate (Estradurin) combined with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)